Results 81 to 90 of about 7,162 (211)
Introduction: In 2014, a complement assay, which evaluates C5b-9 deposition on endothelial cells, was proposed as a biomarker for atypical hemolytic uremic syndrome (aHUS).
Caroline Duineveld +4 more
doaj +1 more source
Atypical hemolytic uremic syndrome (aHUS) is a clinical diagnosis characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal dysfunction. Postoperative aHUS in nontransplant patients is a rare entity.
Anil Khetarpal +2 more
doaj +1 more source
AHUS : Panel discussion, Q&A and scientific exchange
C
Vande Walle, JohanUGent8010005090069774492295780000-0001-9700-5358F4129F7E-F0ED-11E1-A9DE-61C894A0A6B4
core
In 2012 a new community complex opened in Kaitaia, housing the local museum, library, i-Site, hall, theatre and Council offices. This complex is very obviously a meeting place for people of the community and out-of-town visitors. But the site on which the building, Te Ahu, stands has a much longer history as a meeting place.
openaire +3 more sources
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document
Haemolytic uraemic syndrome (HUS) is a clinical entity defined as the triad of nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in which the underlying lesions are mediated by systemic thrombotic microangiopathy (TMA).
Josep M. Campistol +14 more
doaj +1 more source
We report here a young female who underwent a successful deceased donor liver transplant for hepatic vein thrombosis. Five years after transplantation she developed postpartum atypical hemolytic uremic syndrome (aHUS). She did not recover renal function.
Tellez, J. +14 more
core +1 more source
Postoperative Atypical Hemolytic Uremic Syndrome Associated with Complement C3 Mutation
Atypical hemolytic uremic syndrome (aHUS) can be distinguished from typical or Shiga-like toxin-induced HUS. The clinical outcome is unfavorable; up to 50% of affected patients progress to end-stage renal failure and 25% die during the acute phase ...
Eiji Matsukuma +8 more
doaj +1 more source
AbstractIntroductionAtypical haemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) associated with complement dysregulation; aHUS may be associated with other ‘triggers’ or ‘clinical conditions’. This study aimed to characterize this patient population using data from the Global aHUS Registry, the largest collection of ...
Christoph Licht +10 more
openaire +4 more sources
Background Atypical haemolytic uremic syndrome (aHUS) is an uncommon form of thrombotic microangiopathy (TMA). However, it remains difficult to diagnose the disease early, given its non-specific and overlapping presentation to other conditions such as ...
Winston Wing-Shing Fung +5 more
doaj +1 more source
Complement therapy in atypical haemolytic uraemic syndrome (aHUS) [PDF]
Central to the pathogenesis of atypical haemolytic uraemic syndrome (aHUS) is over-activation of the alternative pathway of complement. Inherited defects in complement genes and autoantibodies against complement regulatory proteins have been described ...
Wong EKS, Goodship THJ, Kavanagh D
core

